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1. Introduction 
1.1 HIV and blood transfusion – The current state of the art 
Of all blood donations 65% are made in developed (very high human development index or 
VH-HDI) countries, home to just 25% of the world's population. In 73 countries, donation 
rates are still less than 1% of the population (the minimum needed to meet basic needs in a 
country). Of these, 71 are either developing (low HDI) or transitional (medium to high HDI) 
countries; 42 countries collect less than 25% of their blood supplies from the safest source: 
voluntary non-remunerated blood donors. However, less than 50% of these donors donates 
regularly, the other half just one time only. In 2007, 31 countries (19%) still reported 
collecting paid donations, which is more than 1 million donations in total, where 41 
countries (25%) were not able to screen all blood donations for one or more of the following 
transfusion-transmissible infections (TTIs) – HIV, hepatitis B, hepatitis C and syphilis (WHO 
2010a).  
Blood transfusion as a supportive haemotherapy contributes to saving lives and improving 
health, but millions of patients needing transfusion do not have timely access to or can 
afford safe blood. In 2007, 162 countries provided data to WHO on 85.4 million blood 
donations (World Health Organization [WHO] 2010a). These data come from countries that 
account for a total of 5.9 billion people, representing 92% of the global population. The 
report covers around 8,000 blood centres. In developed countries, the average annual 
collection per blood centre was 13,600 (range 49–289,075), in transitional countries 6,000 
(range 20–499,212) and in developing countries 2,800 (range 114–23,251). 
1.1.1 Blood supply 
While the need for blood is universal, there is still a major imbalance between developing 
and advanced countries in the level of access to safe blood. It is estimated that blood 
donation by 1% of the total population (10 per 1,000 population) is generally the minimum 
needed to meet a nation's most basic requirements for blood; the requirements are higher in 
countries with more advanced health care systems and medical interventions. 
Of the 85.4 milion donations in 2007, about 65 % were collected in developed countries. 
Blood donations per 1,000 population, which also reflect the general availability of blood in 
a country, vary widely and the lowest levels of availability are found in developing and 
transitional countries (WHO 2010a). The average donation rate in developed (VH-HDI) 
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countries is 38.1 donations/1,000 population (range 4.92–68.01); in transitional (H and M-
HDI) countries this rate is 7.5 (range 1.07–35.18) and in developing (L-HDI) countries an 
average of 2.3 (range 0.40–7.46) donations per 1,000 population were collected. In 2007, 73 
countries (45%) reported collecting fewer than 10 donations per 1,000 population. Among 
them, 71 (97%) are either developing or transitional countries. Due to relatively high TTI 
marker prevalence the drop out of collected blood varies between 11 and over 20%, 
reducing the clinical availability substantially. 
1.1.2 Blood donation  
There are three major types of blood donation: voluntary unpaid donations (non-
remunerated/altruistic), family/replacement donations (coerced), and paid donations. 
Donors who give blood voluntarily, regularly and for altruistic reasons have the lowest 
prevalence of HIV, hepatitis viruses and other blood-borne infections, as compared to 
people who donate for friends and family members or because of payment. Family and 
replacement donations are often hidden paid and seriously coerced. Sufficient supplies of 
safe blood can only be assured by regular donations from voluntary unpaid and anonymous 
donors. The 2007 WHO data reveal some improvements in such donations worldwide, but 
many developing and transitional countries still rely heavily on relatively unsafe one time 
only family/replacement donors and paid donors (fig 1).  
This means a considerable gap in public awareness and knowledge about the essentials of 
blood donation as an act of social solidarity and blood transfusion as an integral element of 
the health care system. 
 
 
Fig. 1. Annual blood donations per 1,000 population, 2007. Source: Global Database on 
Blood Safety (GDBS), 2007 survey (WHO2010a) 
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1.1.2.1 Voluntary, unpaid donations  
Of the 162 responding countries 57 (35%) report collecting 100% of their blood supplies from 
voluntary unpaid donors (fig. 2). Since World Blood Donor Day (14th June, birthday of Karl 
Landsteiner) celebration began in 2004, 111 countries (68.5%) reported an increase of the 
number of voluntary donations; 32 of these 111 (29%) have more than doubled the number 
of voluntary donations as compared to 2004 figures. All these 32 countries are developing or 
transitional countries. Additionally, 11 countries (Bosnia and Herzegovina, Burkina Faso, 
Cook Islands, Cape Verde, Kuwait, Guinea Bissau, Mauritania, Myanmar, Niue, Vanuatu 
and Vietnam) reported more than a 10% increase in voluntary unpaid donations in 2007, as 
compared to 2006 figures. However, a major problem remains the retention of voluntary 
non-remunerated blood donors. 
1.1.2.2 Family/replacement donors and paid donors 
Forty-two countries (26%) collect less than 25% of their blood supplies from voluntary 
unpaid blood donors. A significant amount of the blood supply in these countries is still 
dependent on family/replacement and paid blood donors. Thirty-one countries (18%) still 
report collecting paid donations in 2007, which represents more than 1 million donations in 
total. 
The average donation rate in high-income countries is 45,400 donations per million people. 
This compares with 10,100 donations per million people in middle-income countries and 
3,600 donations in low-income countries. If 1% to 3% of a country's population would 
donate blood, it would be sufficient to meet the country's needs. But in 77 countries, 
donation rates are still less than 1%. 
 
 
Fig. 2. Percentage voluntary non-remunerated blood donors, 2007. Source: Global Database 
on Blood Safety (GDBS), 2007 survey (WHO2010a) 
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1.1.3 Blood screening for transmissible infections 
WHO recommends that all donated blood to be used for transfusion should be screened at 
minimum for HIV, hepatitis B, hepatitis C and syphilis (WHO 2010). Complete and accurate 
data on the screening of donated blood are not available from many developing countries, 
particularly those where blood services are not coordinated. Many countries do not have 
reliable testing systems because of staff shortages, lack of basic laboratory services, poor 
quality test kits or their irregular supply. Of the 162 countries that provided data on 
screening for transfusion-transmissible infections including HIV, hepatitis B, hepatitis C and 
syphilis, 41 (25%) are not able to screen all donated blood for one or more of these infections 
(fig. 3). The other 121 countries provided data on whether blood donations were screened in 
a quality-assured manner (use of standard operating procedures and participation in an 
external quality assessment scheme or EQAS). Overall, 88% of the blood collected are 
screened following these basic quality procedures: 89% in developed countries, 87% in 
transitional countries and 48% in developing countries. For the blood donations collected in 
the remaining 41 countries, which account for 22% of the global donations reported to 
WHO, the use of these basic quality assurance procedures for laboratory screening is still 
unknown. Additionally there is still a widespread mix of test kits used within countries, 
both ELISA and rapid test depending on availability and supply. Quality of performance 
and reliability of test results remain a problem of considerable concern.     
1.1.4 Clinical use of blood 
Data on the clinical use of donated blood is limited, but studies suggest that transfusions are 
often given unnecessarily when simpler, less expensive treatments can provide equal or 
greater benefit. Not only is this a waste of a scarce resource but it also exposes patients to the 
risk of serious adverse transfusion reactions or infections transmitted through the blood. 
Hospital transfusion committees and a system for reporting adverse transfusion reactions 
should be established in each hospital to implement the national policy and guidelines and 
to monitor the safe and rational use of blood and blood products at the local level. However, 
in a substantial proportion of the transition and developing countries there is still no 
national policy and no current guidelines or standards. In many situations haemoglobin 
transfusion triggers are high and surgical blood order equations and minimal blood order 
lists are not used (Kajja et al. 2010a, 2010b) . 
In 2007, 120 countries (74%, including 46 developed, 48 transitional and 26 developing 
countries) identified and reported a total of 51,400 hospitals that perform blood transfusions, 
serving a population of around 3.6 billion. Not all countries were able to provide 
information on clinical practice (WHO 2010a). Data on hospitals performing transfusion 
provided by 96 countries (80%, including 38 developed countries, 40 transitional countries 
and 18 developing countries) illustrate the presence of a transfusion committee in 88% of 
these hospitals in developed countries, 33% in transitional and 25 % in developing countries. 
Mechanisms to monitor clinical transfusion practice (documentation) is present in 90% of 
the hospitals performing transfusion in developed countries, 52 % in transitional and 23 % 
in developing countries. However, a system for reporting adverse transfusion events 
(haemovigilance) in hospitals performing transfusion is found in 91% in developed 
countries, but only 46% in transitional and 23% in developing countries.  
These 2007 WHO survey data illustrate a major gap in awareness and knowledge among 
policy makers and blood transfusion professionals, both in the procurement and the 
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prescribing parts of the vein-to-vein blood transfusion chain in transitional (M-HDI) and 
even more prominent in developing (L-HDI) countries. 
 
 
Fig. 3. Numbers of countries screening for HIV, HBV, HCV and syphilis Source: Global 
Database on Blood Safety (GDBS), 2007 survey (WHO 2010a) 
1.2 Basics of the blood supply 
Since UN together with its health organization WHO became operational in 1948, universal 
principles have been laid down in the UN Declaration of Universal Human Rights (UN 
1948). For the health care and blood transfusion chain art. 25.1 – Right of Health through 
securing food, clothing, shelter and health care, and art. 26 – Right of Education, elementary 
and access to vocational education, are paramount.  
In1975 the WHA passed a Resolution 28.72 (Utilization and Supply of Human Blood and 
Blood Products), indicating that blood is a national resource, to be ‘shared’ voluntarily and 
altruistically and to be given as a social act of solidarity, and that human blood and tissue 
should never be subject to commerce (WHO 1978) 
These principles have been worked out by e.g. the International Society of Blood 
Transfusion (ISBT) in the Code of Ethics (ISBT 2000), but also by the EU in the Directives 
related to blood transfusion (EU 2003, Directive 2002/98/EC).  
Blood transfusion in its vein-to-vein structure should be seen as a part of a larger project to 
develop a safe, sustainable, high quality and efficacious blood supply and transfusion 
system that is fully integrated into the health care system. Ensuring the safety and 
availability of blood and blood products is an essential public health responsibility. 
Measures to ensure blood safety also play a major role in preventing the transmission of 
HIV, hepatitis viruses and other blood born pathogens in health care settings. The Ministry 
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of Health (MoH) should provide effective leadership and governance in developing a 
national blood system that is fully integrated into the health care system. First the 
foundation, then the construction of the organization and the necessary infrastructure 
(Quality System and Quality Management System, facilities, etc), will need to be developed.  
These will be followed by the development of the human capacity needed at all levels, 
including in the hospitals (medical and paramedical staff). 
In principle, the approach for developing such an integrated nationally supported and 
organized country wide blood supply and transfusion system for the future, and in line with 
internationally accepted and advocated principles of operation, would then be as follows (fig. 4) 
 
Fig. 4. Development scheme blood supply organization. 
The set up should be based on a solid country specific legislative and regulatory system 
with sufficient authority to license operations according to international quality principles 
(cGMP, cGLP and cGCP)1 supported by appropriate and standardized management 
principles based on ISO9001:2008. It starts with a clinical needs assessment to be followed by 
the logistics of the procurement and supply chain that has its roots in the community (public 
awareness) (Smit Sibinga 2006, WHO 2008c, Smit Sibinga et al 2009a, ). 
The implementation is not limited to public or private blood centres or establishments. The 
limitation is in the fragmentation with insufficient critical mass and economy of scale to 
guarantee quality and cost-effectiveness, nation wide access and affordability. National 
coordination and consistent and sustained governmental responsibility and support to 
protect citizens from unjustified and maleficent practices are the more important (Smit 
Sibinga 2000). 
A nationally coordinated and integrated blood supply system needs competent and 
committed leadership and an appropriate budget to allow accessibility and affordability of 
haemotherapy, based on a proper and documented needs assessment. The financing system 
should be an integral part of a national health financing system based on cost recovery and a 
healthy insurance policy accessible and affordable for all citizens (WHO 2008, van Hulst et 
al. 2006).  
                                                 
1 GMP = Good Manufacturing Practice, GLP = Good Laboratory Practice, GCP = Good Clinical Practice 
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The framework of such an integrated blood supply system could be based on the seven key 
elements (figure 4) as follows:  
1. Organization and structure, including the necessary infrastructure to be strengthened 
and further developed. This element includes the development of an appropriate and 
implementable formal regulatory structure, development of a system of regional blood 
banks based on a sufficient economy of scale to become cost-effective. These institutions 
preferably should be part of a nationally coordinated blood transfusion service 
responsible for policy making, design of the necessary strategies, annual planning, the 
development of a national quality and quality management system based on 
internationally accepted standards and product specifications. Such quality and quality 
management system will have a uniform documentation system, which allows for the 
possibility of instituting a nation-wide ICT system for data management. The 
organization should have sufficient autonomy to operate its services. As the 
organization produces products (collection, processing and testing, storage and 
distribution) for clinical use, it is automatically product liable and should therefore 
operate independently from hospitals. Hospitals use the products for specific 
haemotherapy in patients and therefore have the legal obligation to protect consumer 
rights, which cannot be combined with product liability under the same final 
responsibility (conflict of interest). Another aspect of this first element is the need to 
develop appropriate and cGMP compliant working facilities, that guarantee a working 
environment that allows high quality operations to be performed by staff.  
2. Clinical use needs full attention to develop evidence based transfusion practices all over 
the country. That means assessment of the current clinical practices and development of 
an in-hospital transfusion quality and quality management system. Hospitals will be 
supplied by regional procurement centers (blood centres) with a working stock that will 
be based on an inventory of actual needs per discipline – paediatrics, obstetrics, surgery 
and traumatology and haemato-oncology. The development of a well functioning 
clinical interface will lead to the change from the currently prevalent supply driven 
system to a demand driven system, based on mutual respect and understanding and 
key to the supplier-customer principle of quality operations (Kajja 2010). 
3. Processing and testing of all units of blood collected will allow  an efficient use of the 
blood collected and contribute to rational use of blood through component therapy. 
Testing for the key TTI markers (HIV, HBV, HCV and Syphilis) needs to be instituted 
with appropriate and standardized technology and methodology. Here, economies of 
scale are paramount to guarantee consistency of performance and cost containment. 
Where epidemiology indicates, additional tests can be considered such as brucellosis, 
Chagas or malaria. As screening tests focus on sensitivity, a system for confirmation 
needs to be developed at the national level – a reference laboratory that also could 
perform test kit and reagent validation before implementation is needed. Along with 
the development of component production, in-process quality control of the produced 
half and finished products (testing for standardized and uniform product 
specifications) will be part of the program.  
4. Collection of source material – human blood or plasma – from voluntary non-
remunerated and preferably regular blood donors, motivated and mobilized from 
identified low-risk groups in the community. This requires development of public 
awareness based on social marketing. The currently prevalent supply driven system of 
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the blood supply needs to be developed into a demand driven system, which means the 
availability of motivated potential donors willing to be mobilized to allow a balanced 
blood stock that is managed and the development of a contingency plan. Donor 
selection needs to be standardized and adjusted to internationally recommended 
minimum requirements for donor suitability. 
5. Education (teaching and training) is the cornerstone of capacity building. A national 
assessment and inventory of available education (institutions, curricula) needs to be 
carried out to allow the development of an effective approach towards capacity 
building and human resource development at all levels involved. The in-country 
approach will focus on leadership development (senior and middle management) and 
development of operational competencies (professional knowledge and skills) through 
various education methodologies to allow larger groups of staff to benefit. 
6. Monitoring and evaluation follows the implementation of a national quality and quality 
management system based on uniform documentation of what is being done, both at 
the management level (management information system) as well as at the operational 
level through an automated data processing system (ICT) with communication between 
all centres and the national Head Quarter and Ministry of Health. Use of simple 
statistical evaluation technology such as statistical process control (SPC) and application 
of Six Sigma (Gygi et al., 2005) will allow proper benchmarking focused on 
improvement through trend analysis. A nationwide compatible ICT system would 
allow proper quality management through coordinated monitoring and evaluation of 
uniform data collected through regional centres and hospitals (vein-to-vein). 
7. Sustainability is not only dependent on financial resources, but comprehensively relates 
to all six elements as described above – organizational structure and infrastructure, 
competent and adequate human resources, a reliable and regular voluntary blood 
donor panel, a standardized procurement process, evidence based rational use of blood 
components and alternatives, and quality assurance through proper monitoring of set 
indicators and their evaluation through benchmarking focused on improvement. This 
follows the principle of the Deming cycle of improvement – plan (policy and strategies), 
do (implementation of managerial and operational processes), check (monitoring of the 
indicators/specifications and accurate data collection through documentation), act 
(evaluation of the collected data and the benchmarking).  
1.3 Basics of the clinical use of blood 
The clinical use of blood represents both the starting and the closing end of the demand and 
supply loop. Therefore, it does not make much sense to develop only the clinical interface if 
the basics of proper procurement (collection, processing and testing, storage and 
distribution), based on international principles (1948 UN Declaration of Universal Human 
Rights, 1975 WHA28/72 Utilization and Supply of Human Blood and Blood Products, 
International Red Cross and ISBT Code of Ethics) are not in place. 
The in-hospital transfusion chain should include process analysis, process descriptions, 
related SOPs and operational documents such as a standard (national) blood request form, a 
standard compatibility test form, a transfusion outcome form, clinical guidelines and a 
haemovigilance report form (Kajja 2010). 
The in-hospital transfusion chain consists of three distinctive processes, each containing a 
number of procedures, critical control points (CCPs/decisions) and documentation. (figure 5) 
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Each of these processes has a series of procedures and related documentation that needs to 
be developed: 
1. The blood ordering process (ward/bedside) starts at the bedside with indication setting 
and decision making resulting in a standardized request and accompanying blood 
sample for compatibility testing. Traceability (documentation) is paramount to prevent 
adverse transfusion reactions due to clerical errors of identification (wrong blood in 
tube). It consists of six steps or procedures (diagnosis, indication, decision to transfuse 
or use alternatives, ordering, sample taking and transportation) and two operational 
documents (blood request form and sample label); 
2. The blood selection process (laboratory) of blood components as requested and 
compatibility testing. It should be noted that compatibility testing is a laboratory 
diagnostic procedure. The blood selection process consists of four steps or procedures 
(reception and registration of request and sample, selection of blood, compatibility 
testing and transportation) and two operational documents (logbook and cross match 
form); 
3. The bedside transfusion process (ward/bedside) of the selected units at the bedside, which 
needs careful identification of units and recipient (match), and the technical handling 
and observation of the transfusion, carried out by nursing staff and based on proper 
and uniform standard operating procedures with appropriate documentation to allow 
evaluation necessary to develop evidence based practice. It consists of two sub-
processes:  
a. The preparation of the patient and the unit of blood before the transfusion – three 
steps or procedures (reception at the ward, patient and unit identification, vital 
signs);  
b. Transfusion and observation of the patient – four steps or procedures (connection 
to the patient, immediate observation, transfusion or discontinuation, observation 
of outcome). 
These processes are closely interrelated, though distinctly different. The following steps are 
involved in the process: 
 








3.  Ward   – a. Preparation: ID & vital signs 
 
 
           b. Transfusion/observation 
Fig. 5. In-hospital transfusion flow of steps. 
Clinicians and nursing staff need to be trained in these steps and the related quality 
assurance and documentation to develop a proper and standardized monitoring and 
evaluation evidence based transfusion practice. To create ownership among the prescribing 
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clinicians and nursing staff education should focus on consensus on items such as a uniform 
blood request form, terms of reference of a Hospital Transfusion Committee (HTC) and the 
outline of clinical guidelines (general and per prescribing discipline). 
1.4 Gaps in the blood supply and clinical use 
In many developing countries blood transfusion in the vein-to-vein concept is still in its first 
or second generation stage. This means that blood is most often collected and transfused in 
the absence of a formal policy environment and without adequate regulatory controls or 
standards.  In such systems, blood collection and utilization are fragmented, often 
dependent on independent factors limited to specific hospitals, such as the availability of 
trained and competent staff, funds for procurement, and a population of blood donors 
willing to come on a voluntary and regular basis.  
Following the vein-to-vein transfusion chain, major gaps exist in the following areas: 
1. Organization and infrastructure -  
a. Legal and regulatory frameworks are often outdated or do not exist. 
b. Commitment of health authorities is lacking or isolated in fragmented centres. 
c. Management capacity to sustain blood collection, storage, testing and transfusion 
services differs from routine hospital or laboratory management. 
d. Organization and infrastructure for blood services requires national and facility-
specific assessments and inputs. 
e. Chain of command and clear job descriptions contribute to quality control, stock 
management, and career development. 
f. Quality culture and professional discipline are dependent on successful pre-service 
and on-going in-service training opportunities. 
g. Poor hygiene and waste management may contribute to broader infection control 
problems within a facility and the local community. 
2. Clinical use – 
a. Clinical awareness and accountability among clinicians is essential to avoid 
unnecessary transfusions and preserve limited blood stocks. 
b. Improper indication setting and decision making may increase transfusion 
recipients’ risk. 
c. Informed consent of patients can create additional ethical and legal challenges for a 
facility when not obtained properly (Kajja et al. 2011) 
d. Poor documentation and traceability contribute to wastage; may facilitate fraud, 
and; create barriers to appropriate epidemiological follow-up and tracing in the 
event of an adverse transfusion event. 
e. Communication and understanding between suppliers and users is essential to 
ensure that suppliers (i.e., blood donors) contribute based on a humanitarian 
impulse, not one based on personal gain, and that users (patients and clinicians) 
recognize and consent to the risks related to transfusion. 
3. Processing and testing – 
a. Standards of processing and quality control are a crucial line of defense in patient 
safety and preventing unnecessary wastage. 
b. Inconsistent supply logistics can interrupt quality-associated work routines, 
contribute to unnecessary wastage (out-dating and cold chain spoilage) and 
promote unequal service between regions or facilities (Kajja et al. 2010a, 2010b) 
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4. Collection of source material (community interface) – 
a. Community awareness about the need for blood and the risks of disease 
transmission via transfusion are essential to mobilize a safe donor pool. 
b. Types of blood donors must be actively motivated, selected and screened for safety. 
5. Education – 
a. Education and staff competency: The basis for a quality assured and sustained 
system. (Smit Sibinga, 2009a) 
6. Monitoring and evaluation – 
a. Applied research in the field of transfusion medicine through proper monitoring 
and evaluation (M&E) and continued statistical process control (SPC) can 
contribute to improved operations as well as global understanding of risks, barriers 
and best practices (Smit Sibinga, 2009b). 
2. Principles and ethical aspects of blood donation and transfusion - How do 
these elements promote blood safety? 
Like other medical specializations, the practice of transfusion medicine is bound by the 
ancient Greek Hippocratic mandate Primum est non nocere (first, do no harm). However, for 
transfusion specialists, this principle is not limited to the transfusion itself or to the recipient 
of the transfusion. Rather, it applies to a long chain of ethical decisions that stretches from 
the motivation of potential donors whose blood is used for transfusions to post-transfusion 
follow-up.  This section will describe and explain how each link in this chain contributes to a 
safe blood supply and to safe transfusion practice. 
2.1 Ethical aspects of blood donation 
A brief history of blood donation and transfusion ethics 
The ethical principles that govern the modern vein-to-vein transfusion system were 
developed relatively recently, that is to say, largely within the second half of the 20th 
century, when the science of transfusion medicine became an accepted and routine part of 
medical practice. (American College of Physicians [ACP], 1984)  Indeed, from the 17th 
century, when physicians began experimenting with transfusing animal blood into humans, 
through the late 19th  and early 20th century when blood groups were discovered and 
coagulation factors described, the field of transfusion medicine was marked by 
experimentation, trial and error, and few human subjects protections. (Feldschuh, 1990; 
McCullough, 1998; Kendrick, n.d.) The 1948 Nuremburg Code established a global 
framework for medical ethics following the atrocities committed by Nazi doctors during the 
Second World War. In Europe and North America, laws covering ethical concepts such as 
the requirement that patients give informed consent prior to medical procedures began to 
emerge in the 1950s and 1960s. (ACP, 1984)  In the mid-1930s, the founding of the 
International Society of Blood Transfusion (ISBT), created a global forum for the 
development of specific ethical guidelines for the practice of blood transfusion. Two decades 
later, in 1955, the International Federation of Blood Donor Organizations  (FIODS) was 
established to focus attention on ethical guidelines for the donation of blood and plasma. 
Both entities, as well as authors such as Richard Titmuss (The Gift Relationship: From 
Human Blood to Social Policy, 1971) (Titmuss, 1971), contributed to a body of ethical work 
that lead to the 1975 World Health Assembly resolution containing global recommendations 
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for ethical blood donations and transfusions (WHA 28.72). Those recommendations 
included the following key elements of transfusion ethics: 
1. Blood donations should be voluntary and unpaid. 
2. Countries should collect an adequate supply of blood to be self-sufficient. 
3. Countries should develop legislation and supporting regulations to monitor and control 
the quality of blood collections, blood service laboratory operations (infectious disease 
screening, compatibility testing, production of blood products), and transfusion 
practice. 
These recommendations seem especially prescient following the emergence of the 
HIV/AIDS epidemic in the 1980s, and the identification of blood transfusion as a significant 
route of HIV infection (US CDC, 1982). Between 1980 and 2000, the ISBT and WHO refined 
and adapted these original principles into a global code of ethics whose purpose was “to 
define the ethical principles and rules to be observed in the field of Transfusion Medicine.” The ISBT 
code of ethics is discussed in detail below. Most countries worldwide have blood policies 
based on these fundamental principles (WHO, 2011a). Since 2000, these principles have 
guided numerous global resolutions related to HIV prevention and the emerging donor-
supported field of ‘blood safety’. (PEPFAR, 2005-2010; WHO, 2011b) 
‘Safe blood starts with me’. This commonly used blood donor motivation slogan captures one 
of the principal ethical issues in blood donation, namely that donors share an equal burden 
of responsibility with blood services to ensure the safety of the blood supply (Grainger et al., 
1997). As the sole source of blood for transfusion, donors are indispensible. Yet, donors also 
have rights that must be respected and are, more critically, the principal vector for 
transfusion-transmissible infections. Ensuring the safety of donated blood, therefore, 
requires a balanced, combination approach, including active, education-based and non-
coercive social mobilization practices by transfusion services and donation centres, and the 
active and honest participation of donors in the pre-donation screening process. 
The ISBT Code of Ethics (2000, 2006 revision) contains 11 principles that expand on these 
concepts, especially as they relate to donor health and safety, donors’ right to anonymity or 
confidentiality during and after donation, and donors’ ethical responsibility not to donate if 
they believe their blood may be infected with HIV or another blood-borne pathogen. 
The ISBT code can be collapsed into a chain with four basic links. This pre-donation chain 
describes the individual links that protect donors and the recipients of donated blood. As 
noted above, each of these links contributes to blood safety in a different way. 
Link 1: Mobilizing blood donors without coercion 
Identifying, mobilizing, educating, motivating and retaining an adequate pool of eligible 
and willing blood donors is the primary challenge faced by blood transfusion services 
worldwide. The problem is especially serious in the developing world, where public 
awareness of blood transfusion is low (Elhence, 2006), traditional or cultural beliefs about 
blood may serve as powerful disincentives to blood donation (Umeora et al., 2005), and high 
population prevalence rates for HIV and other TTIs may be a barrier to blood donor appeals 
to the general public (McFarland et al., 1998). In countries with serious blood shortages, the 
impulse to pay or coerce blood donors can be powerful (Parry, 1984). But since the 1980s, 
prompted largely by concerns about transfusion-transmitted hepatitis and HIV, blood 
services in the developed world have largely adopted policies promoting voluntary and 
anonymous blood donation and prohibiting or limiting the payment of donors (ISBT, 
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2006b).2  In the developing world, national blood policies developed since 2000 increasingly 
reflect World Health Organization recommendations that call for blood donors to act on an 
altruistic impulse, not in exchange for money or other kinds of compensation, and for blood 
services to mobilize voluntary, non-remunerated donors. The WHO Aide-Mémoire on 
establishing national blood transfusion services considers this practice ‘the foundation of a safe 
and adequate blood supply.’ (WHO, 2011c) 
The ISBT Code of Ethics (2006 revision) 
Blood Centers: Donors and Donation 
(International Society for Blood Transfusion [ISBT], 2006a) 
1. Blood donation including haematopoietic tissues for transplantation shall, in all 
circumstances, be voluntary and non-remunerated; no coercion should be brought to 
bear upon the donor. A donation is considered voluntary and non-remunerated if the 
person gives blood, plasma or cellular components of his/her own free will and 
receives no payment for it, either in the form of cash, or in kind which could be 
considered a substitute for money. This would include time off work other than that 
reasonable needed for the donation and travel. Small tokens, refreshments and 
reimbursements of direct travel costs are compatible with voluntary, non-remunerated 
donation. The donor should provide informed consent to the donation of blood or 
blood components and to the subsequent (legitimate) use of the blood by the 
transfusion service. 
2. A profit motive should not be the basis for the establishment and running of a blood 
service. 
3. The donor should be advised of the risks connected with the procedure; the donor’s 
health and safety must be protected. Any procedures relating to the administration to a 
donor of any substance for increasing the concentration of specific blood components 
should be in compliance with internationally accepted standards. 
4. Anonymity between donor and recipient must be ensured except in special situations 
and the confidentiality of donor information assured. 
5. The donor should understand the risks to others of donating infected blood and his or 
her ethical responsibility to the recipient. 
                                                 
2 Exceptions exist to this general trend, most notably in paid plasma donations in the United States.  
Other developed countries provide financial or material compensation to donors, or have laws granting 
blood donors time off from work in exchange for donations. (European Commission, 2003, as cited in 
Farrugia et al., 2010; U.S. Food and Drug Administration, 2002) While the push for 100% voluntary, 
non-remunerated blood donations in developing countries has been shown to effectively screen out 
donors at high risk of infection with HIV or other transfusion-transmissible infections (Sarkodie et al., 
2001), an emerging body of evidence suggests that some donors who act for reasons other than personal 
altruism – for instance, family members or others who donate in emergencies or to replace blood units – 
may present no greater risk to the blood supply than first-time volunteer donors (Allain et al., 2009; 
Diarra et al., 2009). Indeed, WHO and others stress the importance of motivating and retaining repeat 
donors ‘who give blood regularly’, as the best way to screen out potential donors with a high behavioural 
risk profile. Yet, despite regular reinforcement of this global guidance, many services continue to 
provide or experiment with some forms of remuneration for blood donors, e.g., cholesterol screening 
(Glynn et al., 2003), distribution of lottery ticket (Stutzer & Goette, 2010), or transportation to and from 
the donation clinic (ISBT, 2006). These divergent findings pose a substantial ethical challenge for blood 
service managers faced with a limited pool of willing blood donors and unmet demand for blood.  
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6. Blood donation must be based on regularly reviewed medical selection criteria and not 
entail discrimination of any kind, including gender, race, nationality or religion. Neither 
donor nor potential recipient has the right to require that any such discrimination be 
practiced. 
7. Blood must be collected under the overall responsibility of a suitably qualified, 
registered medical practitioner. 
8. All matters related to whole blood donation and haemapheresis should be in 
compliance with appropriately defined and internationally accepted standards. 
9. Donors and recipients should be informed if they have been harmed. 
10. Blood is a public resource and access should not be restricted.  
11. Wastage should be avoided in order to safeguard the interests of all potential recipients 
and the donor. 
Link 2: Education is key 
Worldwide, the public must be educated to understand that blood donation supports the 
collective good – that a unit donated today could save the life of a neighbour, a friend, a loved 
one, a stranger, or even the donor himself, tomorrow (‘today me, tomorrow you’). But donors 
must also be educated about the risks associated with donation, both for the donor and for the 
recipient of donated blood. Education materials and programs should emphasize two main 
areas of risk and consent. 
Risks to the donor and consent required prior to donation: 
 The potential for syncope (fainting), hyperventilation, bruising or damage to veins 
during the veinipuncture process. 
 Since most countries test or strive to test 100% of donated blood for pathogens such as 
HIV, hepatitis B and C, and syphilis, donors must be informed of these tests and given an 
opportunity to receive their results with appropriate counselling. In South Africa, the 
South African National Blood Service (SANBS) includes a clear statement about testing 
and the potential emotional impact on donors: ‘Every blood donation is tested for HIV/AIDS. 
Persons testing positive must be aware that this may have a psychological impact and profoundly 
influence their lifestyle.’ (South African National Blood Service [SANBS], 2006) 
Risks to recipients of donated blood: 
 Transmission of infectious pathogens, including HIV. 
 Other adverse transfusion events, e.g. circulatory overload, TRALI, mis-matched blood 
group, allogenic reactions. 
Social mobilization and donor education campaigns will differ depending on the target 
audience.  In many developing countries, youth, especially high-school students, contribute a 
substantial proportion of the national blood supply (Jacobs et al., 1994). However, it should be 
noted that donation camps at schools usually are based on coercion through the school 
authorities. (Los et al., 2009) In addition to confirming the voluntary nature of school-based 
donations, blood services must also study the epidemiology of HIV and other transfusion-
transmissible infections among school-aged donors to ensure that this group actually carries a 
lower risk of infection compared to the general population. Over the last 10 years, several 
successful models to promote blood donation among youth have been established worldwide.  
These include the Club 25 model created by the International Federation of Red Cross and Red 
Crescent Societies (See: http://www.ifrc.org/en/what-we-do/health/blood-services/ 
international-club-25-new-blood-for-the-world/) and the annual WHO-sponsored World 
Blood Donor Day on June 14, the birthday of Karl Landsteiner. 
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Link 3: Pre-donation counselling and behavioural risk screening 
Pre-donation screening occurs after a donor has decided to make a donation, but before the 
blood is collected. The use of behavioural screening – also often referred to as self-exclusion 
screening – allows donors a confidential space in which to reflect on their behavioural risk 
profile and to weigh the consequences of a contaminated donation, especially donations that 
carry a high risk of infection with HIV. Behavioural questionnaires provide the blood 
service with information about lifestyle practices that could increase the donor’s risk of 
carrying a TTI, and work-related information (e.g. do you operate heavy equipment?) that 
could create a safety hazard for the donor immediately after a donation. Questionnaires also 
provide information on medicines the donor is taking or other health conditions that could 
cause adverse reactions in the transfusion recipient or an adverse reaction for the donor (e.g. 
dizziness or fainting). 
In most countries, pre-donation screening includes a written questionnaire and a face-to-
face interview with a trained nurse or a donor counsellor. Questionnaires should ask donors 
simple, yet direct, questions about their general health and lifestyle, especially risky sexual 
practices. The following questions, drawn from the South African National Blood Service 
(SANBS) pre-donation questionnaire, are representative of the kinds of behavioural 
questions donors should be asked in confidence prior to a donation: 
 Have you ever been refused as a blood donor, or told not to donate? 
 In the past six months have you had sexual activity with or without a condom: With 
more than one sex partner?  With a regular sex partner excluding your spouse?  With 
someone whose sexual background you do not know? 
 In the past six months have you:  Had sexual activity with a prostitute or anyone else 
who takes money or drugs or other favours for sex?  Received money, drugs or other 
payment for sex? Been a victim of a sexual assault? 
 Male donors: In the past 6 months have you had oral or anal sex with another man with 
or without a condom?  
 In the past 12 months: Have you had a sexually transmitted disease (STD) e.g. syphilis, 
gonorrhoea, genital ulcers, VD or ‘drop’?   
 Have you ever used needles to take drugs, steroids, or anything not prescribed by your 
doctor or a nurse? 
 Do you think your blood is safe for transfusion to a patient? 
 To your knowledge does your sex partner have other sex partners? 
While the safety rationale justifies this kind of intrusive personal questioning, some 
automatic exclusion criteria, notably YES answers to questions about homosexual sex, have 
sparked ethical debates about the fairness of excluding donors on the basis of sexual 
orientation (Martucci, 2010).  
Link 4: Laboratory screening 
The WHO Aide Mémoire for National Blood Programmes encourages ‘testing of all donated 
blood, including screening for transfusion-transmissible infections, blood grouping and compatibility 
testing.’ However, this WHO recommendation must not be viewed in isolation. Indeed, the 
Aide Mémoire and other WHO guidance stresses that laboratory screening must be part of an 
‘integrated strategy’ that includes the mobilization of low behavioural risk voluntary, non-
remunerated donors, a quality assurance system within the laboratory, and the reduction of 
unnecessary transfusions (WHO, 2011a). Research from high HIV prevalence countries in 
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Africa has shown this integrated approach can have a positive impact on reducing the number 
of donations with incident or ‘window period’ HIV infections that the antigen/antibody 
assays used in most developing countries might not detect  (Basavaraju, 2010). 
The 2010 WHO Guidelines on Screening Donated Blood for Transfusion-Transmissible 
Infections recognize that operational limitations (‘lack of coordination ... inadequate 
infrastructure ... shortages of trained staff ... poor quality systems’) may prohibit some blood 
services from screening all donated units, or create barriers to the implementation of a 
coordinated, integrated laboratory screening program. The guidelines identify the following 
negative outcomes that may occur when laboratory screening systems do not exist or fail:  
 Inefficient screening systems and wastage of resources owing to differing levels of 
operation at multiple sites 
 Lack of quality assurance and quality management systems 
 Use of poor quality test kits and reagents 
 Unreliable, inconsistent supplies and transport conditions of test kits and reagents due 
to poor logistics 
 Equipment failure 
 Variations in laboratory procedures and practices 
 Double standards due to a mix of technologies and methodologies 
 Incorrect storage or inappropriate use of test kits and reagents 
 Inadequate procedures for identification, leading to the misidentification of patient or 
donor blood samples, donations or processed units of blood and blood components 
 Technical failure in testing 
 Misinterpretation of test results 
 Inaccuracies in the recording or transcription of test results.  
 Higher error rates in test results 
 Increased risk of failure to detect TTIs 
 Unnecessary hold time due to poor access to confirmatory tests 
 Unnecessary discard of non-reactive blood 
 Blood shortages and use of unscreened blood in urgent situations 
 Incorrect donor notification and stigmatization. (WHO, 2009) 
2.2 Ethical aspects of blood transfusion 
As noted in section 1.2, Article 25 of the 1948 UN Declaration of Universal Human Rights 
(DUHR) makes reference to individuals’ ‘right to security in the event of ... sickness, disability ... 
or other lack of livelihood in circumstances beyond his control.’  The principle of obtaining patient 
consent prior to performing a blood transfusion or other medical procedure is derived from 
the broad concepts of health and security ... in the event of sickness described in the DUHR. 
Subsequent codes of medical ethics, including the Council of Europe’s 2007 revision of its 
Guide to the Preparation, Use and Quality Assurance of Blood Components; these codes 
expanded on this basic definition of ‘security’ to cover all of the decisions preceding, during, 
and following a transfusion: From confirming the appropriate diagnosis and prescription 
order, to correct patient identification and adverse event monitoring during the transfusion 
itself. (Council of Europe, 2007)  Occasionally, prescribers of blood will encounter patients 
who refuse a recommended transfusion on religious grounds. Clinicians may also face 
difficult decisions with patients who are minors and patients for whom a transfusion may 
extend life but not necessarily improve the quality of the patient’s life; the creation of 
www.intechopen.com
 Transmission of HIV Through Blood – How To Bridge the Knowledge Gap   
 
599 
institutional ethics committees within hospitals and transfusion centres is recommended to 
educate staff about ethical issues; support ethical decision-making; develop ethics codes and 
policies, and; counsel staff and conduct ethical reviews (Perlin, 2001; Kajja et al. 2011).  
Ethical considerations continue even after a successful transfusion, most notably in cases 
where recipients become infected with a transfusion-transmissible infection, or are deemed 
at risk of infection because new information about the donor of the transfused unit comes to 
light (e.g. HIV sero-conversion in the donor). 
The ISBT code of ethics for hospitals and patients contains seven key principles related to 
the transfusion of blood and blood products. 
ISBT Code of Ethics for Hospitals and Patients 
(International Society for Blood Transfusion [ISBT], 2006a) 
1. Patients should be informed of the known risks and benefits of blood transfusion 
and/or alternative therapies and have the right to accept or refuse the procedure. Any 
valid advance directive should be respected. 
2. In the event that the patient is unable to give prior informed consent, the basis for 
treatment by transfusion must be in the best interests of the patient. 
3. Transfusion therapy must be given under the overall responsibility of a registered 
medical practitioner. 
4. Genuine clinical need should be the only basis for transfusion therapy. 
5. There should be no financial incentive to prescribe a blood transfusion. 
6. As far as possible the patient should receive only those particular components (cells, 
plasma, or plasma derivatives) that are clinically appropriate and afford optimal 
safety. 
7. Blood transfusion practices established by national or international health bodies and 
other agencies competent and authorised to do so should be in compliance with this 
code of ethics. 
It should be noted that these seven principles are predicated on an assumption that the 
ethical principles related to blood donors and the screening of blood for transfusion-
transmissible infections have been respected. As with the ethical framework for blood 
donations, these principles can contribute to reduced risks of transfusion-transmissible 
infections by reducing or minimizing the number of inappropriate transfusions. 
3. Assessment techniques and methodologies: Identifying and addressing 
gaps and needs in blood safety programs and blood transfusion services 
Understanding the roles and responsibilities associated with the various departments and 
job descriptions within a blood transfusion service is a complex task, involving layers of 
policy, science, human behaviour, risk, ethics, finances, and, ultimately, medical practice. 
Further identifying gaps, risks and needs within each (or all) of these layers, is an additional 
step that blood transfusion services must take in order to address weaknesses, strengthen 
services, recruit and/or retain staff, improve quality and evaluate the impact of services and 
products provided to transfusion centres  or hospitals and patients. The ultimate goal of 
these objectives is to improve the safety of blood and blood products used for transfusion. 
The U.S. Food and Drug Administration cites the ‘safety, purity, and potency’ of blood 
products as the main rationale for conducting blood service quality audits and assessments 
(Food and Drug Administration, 2010). 
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To accomplish assessment and evaluation objectives, blood services may use a number of 
assessment and evaluation tools, many of which are drawn from business practices (e.g. Six 
Sigma, Total Quality Management, SWOT analyses) or the field of risk analysis. 
International organizations (WHO, ISBT, the IFRCRCS), national blood transfusion services, 
regulatory agencies, and Red Cross/Red Crescent Societies, as well as multilateral and 
bilateral donors (e.g. the European Union, the U.S. President’s Emergency Plan for AIDS 
Relief, the Japan International Cooperation Agency) have also developed assessment tools 
and indicators to assist with the development, implementation and monitoring of blood 
safety projects and programs. 
The field of evaluation has evolved and expanded substantially in the last 20 years. A recent 
PubMed literature search found nearly 250,000 papers dedicated to public health 
evaluations or assessments within the last decade. Beyond the scientific literature, 
thousands of programme reports, guides and other documents in the ‘gray literature’ are 
published each year. This massive diversity of material includes many different 
methodologies, some of which have been used by blood transfusion services to monitor, 
evaluate, assess or audit (Chevrolle et al., 2000) human resource needs (Ferrera et al., 2001), 
blood banking, stock management, laboratory and transfusion practices (Fretz, 2003; 
Dosunmu & Dada, 2005), training curricula (Wehrli, 2011), epidemiological surveillance 
(Roussel et al; Linden & Bianco, 2001 ), and quality systems (Berte, 1997; Mintz, 1995; Smit 
Sibinga, 2001). 
This chapter will review the basic elements these tools are designed off to assess, monitor 
and evaluate.  Examples derived from specific tools and indicators, such as the WHO Global 
Database on Blood Safety, will be presented to highlight the utility of assessment and 
evaluation in the development of strong blood transfusion services, especially in areas with 
high burdens of HIV and other transfusion-transmissible infections. 
As mentioned above in section 1.2, blood services worldwide are built around a framework 
with seven basic components, each of which can be evaluated through techniques such as 
SWOT analyses (Strengths-Weaknesses-Opportunities-Threats), and addressed with the 
principles of the Deming cycle of improvement (Plan-Do-Check-Act): 
1. Structure and organization 
2. Clinical use of blood 
3. Processing and testing 
4. Blood collections 
5. Education and Training 
6. Monitoring and Evaluation 
7. Sustainability 
Within each of these elements, WHO and other blood safety technical assistance programs 
have developed assessment indicators to help blood services identify needs, gaps and risks.  
3.1 The WHO global database on blood safety 
A good place to begin to make sense of the diversity of available materials is the WHO 
Global Database on Blood Safety (GDBS). The GDBS was developed by WHO with expert 
input through the Global Collaboration on Blood Safety (GCBS) and launched in 1998. 
WHO member countries are asked to submit data to the GDBS every two years. The 
indicators collected by the GDBS are periodically revised and increasingly reflect 
collaborative work between WHO and development partners supporting blood safety 
programmes in countries. 
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The GDBS questionnaire contains 253 process, outcome and output indicators clustered 
around eight operational and technical areas (WHO, 2011d) : 
1. Administrative Information  
2. Organization and Management  
3. Blood Donors and Blood Collection  
4. Screening for Transfusion-Transmissible Infections 
5. Blood Group Serology Testing of Blood Donations 
6. Blood Component Preparation, Storage and Transportation 
7. Hospital Transfusion Process and Clinical Use of Blood & Blood Components 
8. Fractionated Plasma Products 
Since its launch, WHO has received and compiled three reports (1998-1999; 2001-2002; 2004-
2005); data collection for a fourth report was begun in 2008. 
3.1.1 Mind the gaps – Recent GDBS findings 
The identification of blood transfusion as a significant vector for HIV transmission in Africa 
in the 1990s (Colbunders, 1991) led to increasing attention and financing for blood safety 
programmes via global health programmes focused on HIV prevention.3 As noted above, 
the epidemiology of transfusion-transmitted HIV also drove the passage of World Health 
Assembly (WHA) resolutions on the blood safety, and the development, over the last 
decade, of WHO’s catalogue of blood safety guidelines and recommendations. In many 
countries this increased attention to blood safety as part of a comprehensive HIV prevention 
strategy has strengthened the whole national blood service – from vein-to-vein – in addition 
to reducing the transmission of HIV through transfusion. Still, despite progress, transfusion 
systems remain weak in many countries, especially those in the lower income strata. The 
most recent GDBS report (2004-2005) highlighted a number of these weaknesses, including: 
 Less than 50% of countries report collecting blood exclusively from voluntary, non-
remunerated blood donors. 
 40% of the 172 countries surveyed, reported having national haemovigilance systems. 
 53% reported having national regulatory bodies for blood transfusion. 
 80% of the world’s population live in countries that collect only 45% of the global blood 
supply. 
3.1.2 Addressing gaps – Achieving change 
Experience and evidence from the field over the last decade has shown that blood services 
in countries with high prevalence HIV have been able to systematically reduce the 
prevalence of HIV in donated blood units by identifying and addressing gaps and 
weaknesses in their operations and structures. In 2008, the U.S. Centers for Disease Control 
and Prevention (CDC) presented data from the PEPFAR blood safety program that showed 
substantial gaps in the legislative and policy frameworks in 14 countries in sub-Saharan 
Africa and the Caribbean (US CDC, 2008). 
Using indicators adapted from the WHO GDBS, CDC asked countries if a national blood 
policy was in place or if the national blood transfusion service (NBTS) was supported by a 
‘legislative framework’ (e.g. laws and regulations). In 2003, only six of the 14 countries 
                                                 
3 Half of the 101 countries that responded to a GDBS question about external support for their blood 
services indicated that they were receiving some kind of international assistance in 2004-2005.  
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reported having a national blood policy; the same year only four of the 14 countries 
reported having a ‘legislative framework’ to support NBTS activities.  By 2007, all 14 
countries had national blood policies in place or in development, and 10 of 14 countries 
had established or were developing ‘legislative frameworks’ based on WHO blood safety 





Table 1. Standards of national blood transfusion policies and legislative frameworks, 
number of whole blood units collected, and number collected per 1,000 population – U.S. 





Table 2. Estimated percentage of persons aged 15-49 years with human immunodeficiency 
virus (HIV) infection, percentage of blood collections reactive for HIV, and percentage of 
collections from voluntary, non-remunerated donors – U.S. President’s Emergency Plan for 
AIDS Relief, 14 countries, 2003-2007 
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During the same four year period, all 14 countries reported lower or stable rates of HIV 
prevalence in donated units (Table 2). 
Although a strict causal association cannot be derived (Noumsi et al., 2008) from these data, 
this report suggests a positive relationship between progress toward addressing policy and 
other operational gaps and improvements in the safety of donated blood for supportive 
haemotherapy. 
4. Evidence based strategies to move from a supply-driven to a demand-
driven blood transfusion system 
4.1 Community specifics for tailor made solutions 
In the majority of economically restricted countries the transfusion chain from vein-to-vein 
is determined by what happens to be available. The supply drives the system. When a 
clinical need occurs, either the scarce hospital or blood bank stock is being used and 
exhausted or family is urged to search for blood donors, whether family related, friends or 
what the market offers. Often that results in under-treatment of patients, unjustified use or 
no treatment at all. The data available for mother and infant death due to shortages illustrate 
this situation (WHO et al. 2010).  
Most of these donors are seriously coerced, time pressure stimulates poor handling and the 
serious and realistic effect of transmission of infections such as HIV, HBV and HCV. 
Besides, it has been observed and documented that hidden stocks are being kept or just 
grow due to shortage in organization and poor logistics of the supply (Kajja I et al., 2010a). 
The chain quite often is interrupted at the clinical interface side, with a serious paucity of 
communication between producer/supplier and prescriber/consumer of blood and blood 
components. The root cause of this paucity is in limited and focused knowledge and related 
practices on either side of the chain. When regular need assessments are being done a better 
idea would grow about the epidemiology of blood transfusion in the hospitals, which then 
could lead to balanced and evidence based logistics of supply of human blood in 
anticipation of the needs. 
As a consequence the blood supply and clinical use should be firmly embedded in the 
health care system with major involvement of the community to allow such anticipatory 
strategies. Community involvement means community education to understand why a 
continuous and not an incidental and ad hoc support is needed (Los & Smit Sibinga, 2001). It 
is the principle of ‘today me, tomorrow you’ as a social act of solidarity. When the blood 
supply becomes a community issue, awareness and responsibility to support with healthy 
blood on a sharing principle, rather than being dragged into blood donation because of 
urgent needs of family and relatives who might die if you would not donate immediately 
(Los & Smit Sibinga, 2001). Questionnaires and testing, whether rapid or ELISA then move 
towards the edge of becoming a farce, seriously jeopardizing the safety of blood transfusion. 
To find out what the knowledge, attitudes and practices of a community are in relation to 
blood donation and transfusion, a KAP (knowledge, attitudes, practices) study could 
certainly be beneficial. KAP studies can be done broad, focused on the community by and 
large or target specific groups, such as presumed low risk categories, known or registered 
blood donors, and non-donors. Each such KAP study will need a careful analysis to unravel 
the underlying anthropological and psychological information needed to understand how 
the mind is set of those who participated and how that relates to community feelings and 
behaviour as a whole. KAP studies should not be incidental, but be part of a mechanism to 
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follow up and study the changes in mind set and behaviour of the community. Only then 
will it provide a useful tool for benchmarking progress in attitude and related practices (Los 
& Smit Sibinga, 2009; Los et al. 2009). 
4.2 Prerequisites – Leadership, awareness, willingness, environment/climate, access 
Unsafe blood transfusions have contributed to the enormous burden of HIV infections in 
various developing parts of the world, in particular in sub-Saharan Africa and the Central 
Asian region (World Bank et al., 2008), and still continue to add to this burden. The risk of 
HIV, HCV and HBV infection through unsafe blood and blood products is exceptionally 
high (95–100%) compared to other common routes of exposure: For example, 11–32% for 
mother-to-child transmission of HIV and HBV and 0.1%–10% for sexual contact. Sub-
Saharan Africa has a particularly high level of transfusion-associated HIV compared with 
other developing regions due to a higher risk of infected blood being transfused. This results 
from a combination of factors: High rates of transfusion in some groups of patients 
(particularly women during labour, and children in the malaria Season), a higher incidence 
and prevalence of HIV infection, dependence on unsafe blood donors and inadequate or 
even absence of testing of blood for HIV in some countries (WHO 2008a, 2010a, 2010b). 
However, also the poor education level and poverty among larger groups in the community 
play an important role. Women and children account for a disproportionate number of HIV, 
HBV and HCV infections through unsafe blood because they are the main groups of 
patients receiving blood transfusion. In developing countries around 50% of the blood is 
transfused to women and 25% to children, largely under the age of 5 years. Up to 20% of 
maternal mortality and 15% of child deaths have been attributed to severe anaemia due to 
malaria. Timely access to safe blood transfusion is a life-saving measure in many of these 
clinical conditions and can also prevent serious illness in these patients. 
Besides the need for identified, competent and designated leadership (Smit Sibinga 2009a, 
2009b), there is the holistic need for awareness – politicians and policy makers, community 
in all its diversity, health professionals and related stakeholders such as hospital managers, 
religious leaders and educators. The government is final responsible for the well being of 
the community and should create the environment and climate for education and 
professional infrastructure to allow awareness and willingness to grow and sustain. The 
organization of the health care should guarantee access and affordability to all in need, and 
the blood supply and clinical prescribers should use and optimize the professional and 
social climate and environment to allow proper, safe and justified practices of procurement 
and clinical use of blood and blood components to be developed and implemented. 
It has been demonstrated that a well organized and structured nationally supported blood 
supply and transfusion system yields a better and safer transfusion practice with a 
minimum residual risk for transmission of blood born infections, in particular HIV/AIDS, 
as compared to a non-cohesive and fragmented blood supply. Any structure should find its 
anchor in an appropriate legal framework – documented principles of blood donation and 
transfusion, adequate regulations and an operational system for audit and inspection of 
compliance with the principles and related operational standards and technical 
requirements (Hollan et al., 1990)  
4.3 Role of education and vocational institutes 
As mentioned in section 2.1 the key factor is competent human capacity at all levels, which 
means education of the community to create public awareness, the professionals to create 
professional awareness and politicians to create political awareness. The awareness to be 
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raised relates to the risks for contracting infectious diseases such as HIV/AIDS, hepatitis, 
malaria and tuberculosis. Additionally these infectious diseases may be spread through a 
variety of contacts, e.g. the blood supply. Education provides knowledge through 
information, which is stored in the brains. A major question and related process is how to 
convert the acquired knowledge into appropriate action. The process depends highly on 
how the information is presented and how the knowledge is perceived. The perception 
ultimately triggers the action needed (WI Thomas & Thomas DS, 1928). 
Education and vocational institutes do play a paramount role in the presentation of 
information and the way the acquired knowledge is perceived individually and collectively, 
leading to individual behaviour and collective or group behaviour – the moral and ethics of 
a community. To bridge the existing knowledge gap, analysis is needed of both the way, the 
environment and the contents of the information offered, and the intellectual mechanisms of 
the perception of the knowledge necessary for the triggering of appropriate action (Los & 
Smit Sibinga, 2009; Kajja, 2010). 
Potential teachers and parents therefore need to be educated on how to pack and present the 
information and how to monitor and evaluate the perception of the knowledge. This 
continuum should have a high rank on the priority list of any nation, filling in one of the key 
universal human rights – the right of education. Competence is the intimate twinning through 
matching of acquiring knowledge and developing skills to act appropriately, whatever is 
concerned. When the community or public understands the need for a healthy life style, for 
sharing regularly a bit of healthy blood with those in need, by donating blood on an altruistic 
and regular basis, when the professionals in the health care understand the need to 
appropriately deal with the collection, processing, testing, storage and distribution of human 
blood as a transplant and at the clinical side with the in-hospital processes of prescription and 
ordering, selection and compatibility testing, and the ultimate transfusion and its monitoring 
and evaluation, the gap will be substantially narrowed and shallowed. However, without a 
proper understanding of the policy makers, the gap will not be bridged completely. 
Evidence-based strategies for blood safety and availability have been successfully 
implemented in most developed countries and some transitional and developing nations. 
However, despite the proven effectiveness of these strategies, many countries are making 
slow progress towards their implementation. There is ample evidence that a nationally 
supported blood supply and clinical use of human blood, well regulated and professionally 
implemented on an adequate economy of scale, leads to a significant reduction in risk of 
transmission of infectious diseases.  
Such nationally supported approach covers the entire nation and is based on education of all 
parties involved, understanding the importance and relevance of the necessary and ongoing 
provision of information and related actions. 
Such systems recognize and address the potential weaknesses and gaps as listed above in 
the 6 major areas of transfusion medicine - 1.  Organization and structure; 2. Clinical use 
(clinical interface);  3. Processing and testing; 4. Collection of source material (community 
interface); 5. Education; 6. Monitoring and evaluation (research and development). 
Such systems are based on the needs of the community to be met by the supply through 
anticipation, proper planning and adequate logistics (Smit Sibinga, 2000). The demand then 
will drive the supply and no longer the other way around.  
5. Directions for improvement – Values and realities 
Over the past few decades, since the outbreak of the HIV/AIDS epidemic, much work has 
been done to provide a better understanding of the routing of transmission of the virus. There 
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are prominent differences in the various cultures in the perception of the risks related to 
behaviour, personal and collective. That relates to different standards of moral and ethics, of 
values of life and realities of human attitudes and behaviour. Education remains a key factor in 
the provision of knowledge and related perception needed for action to prevent transmission, 
both vertical and horizontal. Blood transfusion in the vein-to-vein concept lacks behind in its 
development despite the continuum of initiatives developed by organizations such as the 
World Health Organization (WHO), the International Federation of Red Cross and Red 
Crescent Societies (IRC), the International Society of Blood Transfusion (ISBT) and the World 
Federation of Hemophilia (WFH) (Smit Sibinga, 2002). The WHO Blood Transfusion Safety 
Programme at WHO-HQ, Geneva, evolved from the WHO Global Programme on AIDS and 
the Global Blood Safety Initiative (GBSI) of the late 1980s. The leadership role of WHO has 
become visible through the development of a number of tools for education, collecting data, 
and providing guiding documents such as the series of Aide Mémoires to support and advise 
Governments in their attempts to structure national blood supply systems on a cost-effective, 
safe and sustainable basis. The Global Blood Safety Initiative started to map the situation of the 
blood supply and clinical use in the world and provide a series of expert advises, including 
two documents on education in transfusion medicine (WHO 1992a, 1992b).  
5.1 WHA resolutions 
With the goal of ensuring universal access to safe blood, WHO has been at the forefront of 
the movement to improve blood safety as mandated by successive World Health Assembly 
resolutions. In 2007 an important global meeting took place in Ottawa, Canada, addressing 
in a global consultation crucial aspects of a universal access to safe blood all part of the 
identified gaps (WHO, 2008a). More than 30 years after the first World Health Assembly 
resolution (WHA28.72) addressed the issue of blood safety, equitable access to safe blood 
and blood products and their safe and rational use still remain major challenges throughout 
the world. While the demand for blood is growing in the advanced world with longevity of 
life and increasingly sophisticated clinical procedures, national blood supplies are rarely 
sufficient to meet existing requirements in the restricted economy part of the world with 
some 80% of the global population. 
Since that first World Health Assembly Resolution, a series of Resolutions has been created, 
endorsed and signed by the Member State representatives in an attempt to stimulate 
implementation at national level (Table 3). A recent one, WHA63.12 on Availability, Safety 
and Quality of Blood Products, was endorsed in May 2010 and urges Member States – 
1. to take all the necessary steps to establish, implement and support nationally-
coordinated, efficiently-managed and sustainable blood and plasma programmes 
according to the availability of resources, with the aim of achieving self-sufficiency, 
unless special circumstances preclude it; 
2. to take all the necessary steps to update their national regulations on donor assessment 
and deferral, the collection, testing, processing, storage, transportation and use of blood 
products, and operation of regulatory authorities in order to ensure that regulatory 
control in the area of quality and safety of blood products across the entire transfusion 
chain meets internationally recognized standards; 
3. to establish quality systems, for the processing of whole blood and blood components, 
good manufacturing practices for the production of plasma-derived medicinal products 
and appropriate regulatory control, including the use of diagnostic devices to prevent 
transfusion transmissible diseases with highest sensitivity and specificity; 
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4. to build human resource capacity through the provision of initial and continuing 
education (teaching and training) of staff to ensure quality of blood services and blood 
products; 
5. to enhance the quality of evaluation and regulatory actions in the area of blood 
products and associated medical devices, including in vitro diagnostic devices; 
6. to establish or strengthen systems for the safe and rational use of blood products and to 
provide education (teaching and training) for all staff involved in clinical transfusion, to 
implement potential solutions in order to minimize transfusion errors and promote 
patient safety, to promote the availability of transfusion alternatives including, where 
appropriate, autologous transfusion and patient blood management; 
7. to ensure the reliability of mechanisms for reporting serious or unexpected adverse 
reactions to blood and plasma donation and to the receipt of blood components and 
plasma derived medicinal products, including transmissions of pathogens 
(haemovigilance); 
The red thread through all these resolutions is the prevention of further spread of 
HIV/AIDS through contaminated blood transfusions and improving patient care, 
addressing the major knowledge gaps.  
 
The global need for blood safety and availability has been highlighted in the following 
WHA and Executive Board (EB) resolutions and regional resolutions (PAHO and AFRO) 
that provide specific direction on strategies and activities within individual regions: 
1975: 
WHA Resolution WHA28.72: Utilization and Supply of Human Blood and Blood 
Products 
1987: EB Resolution EB79.R1: Blood and Blood Products 
1995: WHA Resolution WHA48.27: Paris AIDS Summit 
1999: 
DC-PAHO/AMRO Resolution CD41.R15: Strengthening Blood Banks in the 
Region of the Americas 
2000: WHA Resolution WHA53.14: HIV/AIDS: Confronting the Epidemic 
2001: 
RC-AFRO Resolution AFR/RC51/R2: Blood Safety Strategy for the African 
Region 
2002: WHA Resolution WHA55.18: Quality of Care: Patient Safety 
2003: WHA Resolution WHA56.30: Global Health Sector Strategy for HIV/AIDS 
2005: 
WHA Resolution WHA58.13: Blood Safety: Proposal to Establish World Blood 
Donor Day 
2007: 
WHA Resolution WHA60.24: Health Promotion in a Globalized World 
WHA Resolution WHA60.29: Health Technologies 
2010: 
WHA Resolution WHA63.10: Partnerships 
WHA Resolution WHA63.12: Availability, Safety and Quality of Blood Products 
WHA Resolution WHA63:18: Viral Hepatitis 
WHA Resolution WHA63:19: WHO HIV/AIDS strategy for 2011–2015 
WHA Resolution WHA63:20: Chagas Disease: Control and Elimination 
Table 3. WHA Resolutions related to blood safety. 
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5.2 Millennium development goals 
The United Nations Millennium Development Goals (MDG) are eight goals that in 2000 all 
191 UN Member States have agreed to try to achieve by the year 2015 (UN, 2000). The 
United Nations Millennium Declaration, signed in September 2000 commits world leaders 
to combat poverty, hunger, disease, illiteracy, environmental degradation, and 
discrimination against women, all essential parts of the original 1948 UN Declaration of 
Universal Human Rights.  
The eight MDGs are derived from this UN Millennium Declaration. 
1. to eradicate extreme poverty and hunger; 
2. to achieve universal primary education; 
3. to promote gender equality and empower women; 
4. to reduce child mortality; 
5. to improve maternal health; 
6. to combat HIV/AIDS, malaria, and other diseases; 
7. to ensure environmental sustainability; 
8. to develop a global partnership for development. 
All eight goals have specific targets and indicators. Of these eight goals, the numbers 4, 5 
and 6, and eight of the 18 targets relate directly to health and safe blood transfusion. The 
number 2 relates to education and the number 8 to the role of partnership for development, 
equally important to the development of safe and efficacious blood transfusion practices.  
Some developing countries have made impressive progress in achieving the health-related 
Millennium Development Goals, targets and indicators. However, many more are still 
falling behind. Progress is particularly slow in sub-Saharan Africa but also in other 
developing and transition countries such as a number of the Newly Independent States 
(NIS), where knowledge gaps remain a major issue to address.  
5.3 Success stories 
There is a steadily growing number of success stories on bridging the knowledge gap and 
improving on the safety of the blood supply. We present just a few recent examples, largely 
from the African continent. 
Eritrea (Baraki et al., 2010) - In 2006, despite the production of blood components in the 
National Blood Transfusion Centre (NBTC), about 90% of blood requests were for whole 
blood, an evidence of inappropriate use of blood and blood components in Eritrea. This 
could be the result of absence of proper and up to date guidelines and lack of training in 
appropriate use of blood and blood components, and alternatives. To change, the NBTC 
adapted clinical guidelines from the WHO document on appropriate use of blood (WHO, 
2001). Copies of this document were distributed to all hospital staff in the country followed 
by training to the guidelines. 
Objective of this Swiss Red Cross and Academic Institute IDTM (Groningen, NL) supported 
project was to assess the impact of distributing clinical guidelines and training 
(interventions) on knowledge, attitude and practice (KAP) of clinical prescribers in blood 
transfusion before and after the interventions. Correctly responded knowledge, attitude and 
practice (KAP) questions were collectively considered. Baseline: 3.8 percent of respondents 
correctly answered all KAP questions, which increased to 6.1 percent after the intervention. 
Of the total KAP questions, the average correct responses were 15.86 in the baseline and 
17.45 in the follow-up assessment. The difference was positive and statistically significant 
(p<0.000) demonstrating the intervention had a major impact in changing the overall 
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knowledge, attitude and practice of these health workers. When certain tools were audited, 
the compliance was found to be 38.1 percent among the assessed hospitals, though the 
auditing was limited to seven (7) major hospitals. This shows the intervention has made an 
impact when compared with the pre-intervention status. 
When blood and blood components utilization comparison was made before (2006) and 
after the intervention (2008), demand for whole blood had decreased whereas the demands 
for all blood components had increased significantly (except FFP which remained 
unchanged). 
This shows the progress made in Eritrea through focused education in addressing safe 
transfusion practice, and the measurable improvements in that practice.  
Malawi (courtesy Dr. Jean C. Emmanuel) – Malawi (population of ± 11 million) is a Low 
Human Development Index (L-HDI) country. The European Union EC EDF VIII Project 
document set out to develop an independent and sustainable National Malawi Blood 
Transfusion Service (MBTS) following the recommendations and guidelines of the World 
Health Organisation (WHO), International Federation of Red Cross and Red Crescent 
Societies (IFRCRCS) and the International Society of Blood Transfusion (ISBT). The MBTS 
project plan was based on sustainable and effectively managed and organised independent 
National Blood Services. The platform for development was the establishment of a Finance 
and Administration department, with an experienced chartered cost accountant (CPA) as 
Director; with facilities and trained staff. Effective collaborative networks have been 
established with Ministry of Health (MoH) and Ministry of Finance (MoF), ensuring 
incorporation of a sustainable budget into the national annual fiscal budget, negotiated ‘fee 
for service’ from the private health insurance schemes for the private sector, and an 
equitable career structure for all staff with social benefits to ensure continuous capacity 
building and retention of staff. MBTS Trust Board appointed an experienced CEO; Finance 
& Administration Director and Medical Director. 
In February 2000 a financing agreement, MAI/7001/002, was signed between the Republic 
of Malawi and the European Commission (EC) for € 7.8m in order to support the Malawi 
MoH to establish an independent National MBTS under a formally constituted and 
independent Malawi Blood Transfusion Service Trust. Project funding was increased with a 
further € 1.3m following a successful mid-term review (MTR). The Project Manager was 
appointed in March 2003 and development commenced. The Board of Trustees is 
responsible for the effective operation of MBTS and drafted appropriate legal frameworks, 
comprising the Constitution for the Board of Trustees and Legislation of the Service. MBTS 
is an officially registered Non Government Organisation (NGO) with a legal seal. MBTS is 
managed and organised by a competent Chief Executive Officer (CEO) who has 
internationally recognised qualifications, a Finance and Administrative Director and 
Medical Director with a Deputy; together form the Senior Management Team reporting 
directly to the Board. Developing collaborative working partnerships with the relevant 
NGOs, stakeholders and bodies in the private and public sector in Malawi is an important 
and ongoing strategy. 
The overall objective of MBTS is to provide safe blood and blood products, reduce the 
incidence of HIV, and other diseases transmissible by blood, ensuring equitable access and 
availability of blood and promoting appropriate clinical use of blood.  The goal was 
achieved within the planned project timeframe a sustainable, national blood transfusion 
service providing a safe, adequate and accessible supply for all those in need in recognised 
health care establishments from 100% voluntary non-remunerated safe blood donors, which 
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meets the needs of all hospitals in Malawi through the three centres specifically designed 
and built within the project framework. 
The five-year project ended 2007. An independent Mid Term Review (MTR) Team 
contracted by European Commission (EC), concluded that the project had been successfully 
implemented. As a result EC agreed to an extension to the funding of  € 1.3m through EDF 
IX, for the construction of 3 Blood Centres. 
Key achievements of the project: 
- Establishment of an approved and effective Board of Trustees, CEO and Executive 
Team, with effective leadership, organisation and management, personnel (110 staff) all 
trained to international standards in all areas of work, with job descriptions, SOPs and 
implementing quality systems; 
- MBTS policy, plan and legal framework approved as official legal instruments; 
- Construction of 3 blood transfusion centres (completed 2008); 
- Equipment and vehicles for 8 mobile collection teams including a blood donor bus; 
- Recurrent expenditure secured in fiscal budget by ‘subvention’ from fiscal year 
beginning July 2006 to present; 
- Project Manager/Technical Assistance funded by EC responsible for development and 
training ended 31 March 2007; 
- All objectives, and planned outputs, were achieved on time; 
- All donated blood is tested for HIV I/ II, p24 antigen; Hepatitis B & C; Syphilis and 
malaria with the introduction of a quality management system, and good laboratory 
practices.  Trained senior staff have become trainers of district hospital blood bank staff 
and future MBTS staff; 
- Blood Cold Chain (BCC) system in place for the transport of blood specimens for 
centralized testing and distribution of blood and blood products to all hospitals; 
provision of targeted hospitals with appropriate resources for the storage of blood and 
blood products for blood transfusion; 
- District Hospital laboratory staff have been trained using WHO Distance Learning 
Materials (every technician has a personal copy);  
- Training workshops, seminars and lectures on appropriate clinical use of blood 
facilitated by respective senior staff; 
- Research ongoing on knowledge, attitudes and practices (KAP) on blood donation 
issues; evaluating prevalence of Hepatitis C (HCV); on evidence based rationale for 
individual patient identification arm bands; research paper co-authored on Clinical 
Paediatric Transfusion Guidelines; 
- MBTS provides blood and products from 100% voluntary non-remunerated donors to 
all public and private hospitals; 
- MBTS is a sustainable and effective Service with an approved fiscal budget and a “fee 
for service” through private medical insurance.  
Sudan (Hassan Ali et al., 2010) - In Sudan blood transfusion services were fragmented - 
hospital based with 85% of blood collected from family and replacement donors. More than 
300 hospital blood banks practice blood collection and transfusion; 40% are rural hospitals 
with transfusion rate of 5-100 units of blood per month besides large central and specialized 
urban hospitals with transfusion rate of 100-300 units of blood per month. About 300,000 
units of blood are collected annually; 56% is screened using rapid tests and 44% by ELISA 
technique, with a TTI marker prevalence of HIV - 2%, HBV - 6%, HCV - 2% and syphilis - 
5%. Apart from a few solitary guidelines and SOP-like instructions no quality system was in 
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place. Almost exclusively whole blood is being transfused and adverse events are poorly 
observed. In 2009, in close collaboration with World Health Organization and the Academic 
Institute IDTM (Groningen, NL), a project to improve quality in blood transfusion through 
an appropriate quality management system was established, focused on the creation of a 
solid national blood supply and transfusion framework. Objectives were to review existing 
quality management programme and identify gaps, assist in the development of a draft 
national quality policy and develop a plan for quality improvement including capacity 
building. Through a series of field visits to main blood transfusion centres in three main 
States, the establishment of a National Steering Committee to create full ownership, capacity 
building through basic education in quality management and clinical transfusion medicine 
(quality culture) and enhancement of a voluntary blood donation programme strategy, the 
following goals were reached –  
1. Endorsed National Blood Transfusion Policy (Ministry of Health);  
2. Voluntary Blood Donor Association established and registered;  
3. 50 senior blood bank quality managers from 10 States educated in the basics of quality 
management. Committees from these trainers have worked on developing a draft 
national quality manual;  
4. 6 seminars for prescribers conducted in 3 States, to improve clinical blood transfusion 
knowledge and practice (in-hospital transfusion chain). 
This demonstrates that international collaboration (WHO/IDTM) can generate major 
achievements in establishing a national framework and improving quality blood transfusion 
services in developing countries to achieve the goals of safe and adequate blood supplies 
and clinical  awareness and knowledge at national level. 
Uganda (Kyeyune et al., 2010) - In 1957, a centralized transfusion service - the Uganda Blood 
Transfusion Service (UBTS), was started at Nakasero. This supplied blood to the entire 
country for the following 20 years. The period from 1977 to 1987 saw political unrest disrupt 
national infrastructures and aggravated the human resource crisis in the health sector. This 
resulted into reversion to the original unregulated hospital based transfusion service 
nationwide. Like any other low HDI country, Uganda is still challenged by a low availability 
of voluntary non-remunerated blood donors (VNRBD); insufficient transport and storage 
facilities; low capacities in testing of donated blood and quality assurance in testing 
laboratories. Through a step-by-step approach these problems are being reversed using 
locally and internationally sourced technical and financial support. In May 1987, Uganda 
with the assistance of the Global Programme on AIDS (GPA) of the World Health 
Organization (WHO) held a financial donor conference in Kampala. As a result, the Uganda 
AIDS Control Programme (UACP) was formed. The European Commission (EC) through its 
AIDS Task Force (ATF) made a pledge of 1.5 million Euros to rehabilitate the central blood 
bank at Nakasero and the collection, processing and distribution of 10,000 units of whole 
blood to be supplied to hospitals within 100 kms from Nakasero Blood Bank. In the period 
1989-2004, further funding from EC together with adequate technical advice and support 
enabled the UBTS to improve its infrastructure by opening four regional blood banks in 
Mbarara, Fort-Portal, Gulu, Mbale and two satellites in Arua and Kitovu. This was 
accompanied by development and adoption of a National Blood Transfusion Policy, and 
organization and coordination of a national safe blood transfusion service based on 
voluntary non-remunerated blood donors. This period saw significant reduction of HIV and 
hepatitis B sero-prevalence among donors. A quality assurance programme was instituted 
in the UBTS establishment, and opportunities for human resource development in-service 
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training were initiated. The EC fund was phased out in 2004 amidst increasing demands for 
safe blood for an increasing population. From 2004 to date UBTS has enjoyed technical (TA 
provision) and financial support from the US PEPFAR project, focused on strengthening of 
the national blood transfusion service. This has been followed by renovation of existing and 
establishment of new facilities, increased blood collection from 107,000 units in 2004 to 
165,500 units in 2009. Blood testing for hepatitis C was started in 2005 in addition to HIV, 
Hepatitis B and syphilis testing. Hospital transfusion committees to oversee clinical use of 
blood are being created, and a major emphasis is on quality system essentials and capacity 
building in the regional blood banks. 
Uzbekistan (Makhmudova & Smit Sibinga, 2008) - Project focus: development of a 
Republican Blood Supply and Transfusion System based on international standards – safe, 
efficacious, sustainable and affordable. 
The Government of Uzbekistan initiated measures to reform the Health Care System. 
Government and Asian Development Bank (ADB) signed a Loan Agreement (2004) for a major 
project: Woman and Child Health Development (WCHD); part is used to improve blood 
services. The blood services situation requires radical improvement: Donated blood is not safe, 
majority is collected from paid donors with serious risk of HIV, HCV and HBV transmission. 
The country lacks a national blood safety policy, strategic plan, appropriate legislative and 
regulatory framework. The Blood Safety Program (component 3) of WCHD comprises a 
nationwide blood supply system, initiated in 2004 and substantiated in 2006, based on WHO 
and Red Cross principles. The programme is public health oriented, addressing the need for a 
nationally supported system, cost-effective, motivation and mobilization of the community to 
convert the current paid and replacement system into a truly voluntary and regular blood 
donor system, upgrading procurement operations (regional and economy-of-scale). It 
addresses the need for equitable access of safe blood to all citizens, appropriate clinical 
practices, and a national budget system to allow sustained and continuous operations. Using 
public education and social marketing campaigns with the support of NGOs, a voluntary and 
regular donor programme will be implemented stepwise. Another major point is in 
establishing appropriate clinical transfusion practices. With support of international expertise, 
MoH has created a Republican reform plan to reduce the number of inadequate hospital based 
blood transfusion units. The plan focuses on consolidation of core activities - blood collection, 
processing and testing, storage and distribution in 6 regional centres, strategically spread over 
the country to be able to handle logistics of demand and supply, and provide cost-effective 
operations. Implementation is in phases to allow proper adaptation and guarantee of 
continued supply of blood over the transition period. The WCHD conducts training needs 
assessments, develops training modules based on WHO guidelines and provides education for 
clinicians and transfusion medicine specialists (capacity building). Another example of how to 
bridge the knowledge gap. 
This demonstrates that donor funding when appropriately utilized and supported by 
adequate provision of guidance and technical advice can improve blood transfusion 
programmes in the low human development index countries. 
5.4 Lessons learned 
To reduce the burden of morbidity and mortality through HIV infected blood transfusions 
of particularly the poor and marginalized populations, the focus should be on an increasing 
access to clinical and diagnostic technology, safe blood, blood components and medical 
devices. This could be achieved through reducing the leading risk factors to human health 
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in which lack of education (knowledge) plays a major role. When a safe and professional 
environment for the vein-to-vein use of blood and blood components is created, the risk for 
transmissible and transfusion related diseases will be reduced. At the same time there 
should be developed a sustainable and integrated health care system by building competent 
leadership, management and operational capacity in the methodologies and technologies 
involved in the procurement and clinical use of blood and blood components as 
fundamental elements of a sustainable health care system. 
That could only be achieved sustainably when enabling policies and an institutional 
environment are developed through appropriate national drug and blood policies (legal and 
regulatory framework), with all partners involved in the health technologies and within the 
framework of national health policies (integrated), which generate a common vision and a 
realistic and feasible plan for action. 
6. Acknowledgement 
The authors would like to acknowledge Dr. Yifdeamlak E. Baraki from Eritrea, Dr. Jean C. 
Emmanuel from Malawi, Dr. Abdul Hassan Ali from Sudan, Dr. Dorothy Kyeyune from 
Uganda and Dr. Mayya Makhmudova from Uzbekistan for their invaluable contribution to 
the success stories. 
7. References 
Adriani WPA, Smit Sibinga CTh.  How to develop a practical Quality Management System in 
resource limited countries, Vox Sanguinis, Vol. 95, Issue 241 (Suppl), pp. 501 
Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S. (2009). Relative safety of first-time 
volunteer and replacement donors in west Africa, Transfusion, Vol. 50, pp. 340-3 
American College of Physicians Ad Hoc Committee on Medical Ethics (Eds.). (1984). 
American College of Physicians Ethics Manual Part I: History of Medical Ethics, The 
Physician and the Patient, The Physician's Relationship to Other Physicians, The 
Physician and Society, Annals of Internal Medicine, Vol. 101, Issue 1 (July 1984), pp. 
129-137 
Baraki Y, Swiss Red Cross, Smit Sibinga CTh. (2010). The Impact of Introduction of Clinical 
Guidelines and Training in Appropriate Use of Blood and Blood Products (AUB) on 
Knowledge, Attitude and Practice of Blood Prescribers in Eritrea. Transfusion, 2010;50 
(2S):187A 
Basavaraju S et al. (2010).  Reduced risk of transfusion-transmitted HIV in Kenya through centrally 
co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV 
antibody screening, Vox Sanguinis, Vol. 99, Issue 3 (October 2010), pp. 212–219 
Berte LM. (1997). Tools for improving quality in the transfusion service, American Journal of 
Clinical Pathology, Vol. 107, Issue 4 Suppl 1 (April 1997), pp. S36-42 
Chevrolle F et al. (2000). Blood transfusion audit methodology: the auditors, reference systems and 
audit guidelines, Transfus Clin Biol, Vol. 7, Issue 6, (December 2000), pp. 559-62 
Colebunders R et al. (1991). Seroconversion rate, mortality, and clinical manifestations associated 
with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, 
Zaire, Journal of Infectious Diseases, Vol. 164, pp. 450–6 
www.intechopen.com
  
HIV and AIDS – Updates on Biology, Immunology, Epidemiology and Treatment Strategies 
 
614 
Council of Europe (2007). Chapter 30: Pre-transfusion Measures, In: Guide to the 
Preparation, Use and Quality Assurance of Blood Components, Accessed March 25, 








Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. (2009). HIV, HCV, HBV and syphilis rate 
of positive donations among blood donations in Mali: lower rates among volunteer blood 
donors, Transfusion Clin Biol, Vol. 16, pp. 444-7 
Dosunmu AO, Dada MO. (2005). Principles of blood transfusion service audit, African Journal of 
Medical Science, Vol. 34, Issue 4 (December 2005), pp. 349-53 
European Union. (2003). Directive 2002/98/EC of the European Parliament and the Council 
of 27 January 2003 Setting standards of quality and safety for the collection, testing, 
processing, storage and distribution of human blood and blood components and 
amending Directive 2001/83/EC Official Journal of the European Union 2003 
I.33/30-39 
Farrugia A, et al. (2010). Payment, compensation and replacement – the ethics and motivation of 
blood and plasma donation,Vox Sanguinis, Vol. 99 (June 2010), pp. 202-211 
Feldschuh J, with Weber D. (1990). Safe Blood: Purifying the Nation's Blood Supply in the Age of 
AIDS, The Free Press, 0-02-910065-8, New York 
Ferrera V et al. (2001). Methodology for the development of a program for following and 
maintaining the competency of human resources, Transfusion Clin Biol, Vol. 8, Issue 1 
(February 2001), pp. 30-43 
Fretz C. (2003). Self-Assessment Tools, Transfusion Clin Biol, Vol. 10, Issue 2 (April 2003), pp. 
94-8 
Glynn SA, Williams AE, Nass CC, Bethel J, Kessler D, Scott EP, Fridey J, Kleinman SH & 
Schreiber GB. (2003). Attitudes toward blood donation incentives in the United States: 
implications for donor recruitment, Transfusion, Vol. 43, Issue 1 (January 2003), pp. 7-
16 
Grainger B, Margolese E, Partington E. Legal and ethical considerations in blood transfusion, 
Canadian Medical Association Journal 1997; 156 (11 suppl) 
Gygi C, DeCarlo N, Williams B. (2005) Six Sigma for Dummies. Wiley Publishing Inc. ISBN: 0-
7645-6798-5, Hoboken, NJ, USA  
Hassan Ali A, Abdellah YE, Smit Sibinga CTh. (2010)  International Collaboration: an Approach 
to Establishing Blood Transfusion Quality System in Sudan, Vox Sanguinis 2010;99 
(suppl 1):92 
Hollán SR, Wagstaff W, Leikola J, Lothe F. (eds.). (1990) Management of blood transfusion 
services. WHO Press, Geneva, CH 
International Federation of Red Cross/Red Crescent Societies (IFRC).  
International Society of Blood Transfusion [ISBT]. (2006) International Forum: Paid vs. unpaid 
donors, Vox Sanguinis, Vol. 90, No. 1, pp. 63-70. 
www.intechopen.com
 Transmission of HIV Through Blood – How To Bridge the Knowledge Gap   
 
615 
International Society of Blood Transfusion [ISBT]. (2006) ISBT Code of Ethics for Blood 
Donation and Transfusion, In: Documentation, Accessed March 23, 2011, Available 
from: http://www.isbt-web.org/documentation/default.asp 
Jacobs B et al. (1994). Secondary school students: a safer blood donor population in an urban with 
high HIV prevalence in east Africa, East Africa Medical Journal, Vol. 71, Issue 11 
(November 1994), pp. 720-3 
Kajja I, Bimenya G, Smit Sibinga C. (2010b) The interface between blood preparation and use in 
Uganda, Vox Sanguinis  2010;98:e257-e262   
Kajja I, Bimenya GS, Eindhoven GB, ten Duis HJ, Smit Sibinga CTh. (2010b) Surgical blood 
order equation in femoral fracture surgery, Transfusion Medicine; 2010: doi: 
10.1111/j.1365-3148.2010.01033.x  
Kajja I, Bimenya GS, Eindhoven GB, ten Duis HJ, Smit Sibinga CTh. (2010a) Blood loss and 
contributing factors in femoral fracture surger, African Health Sciences 2010;10:18-25 
Kajja I, Bimenya GS, Smit Sibinga CTh. (2011) Informed consent in blood transfusion: Knowledge 
and administrative issues in Uganda hospitals, Transfusion and Apheresis Science 
2011; 44:33-39 
Kajja I, Kyeyune S, Bimenya GS, Smit Sibinga CTh. (2010a) Bottlenecks of blood processing in 
Uganda, Transfusion  Medicine, 2010;20:329-336 
Kajja, I (2010). The Current Hospital TransfusionPractices and Procedures  in Uganda, PhD 
Thesis, GrafiMedia RUG, ISBN 978-90-367-4619-9 
Kendrick DB. (n.d.). Blood Program in World War II, In: Medical Department United States 
Army in World War II, Accessed March 25, 2011, Available from: 
http://history.amedd.army.mil/booksdocs/wwii/blood/default.htm 
Kyeyune D, Kataaha P, Kajja I, Smit Sibinga CTh. (2010) The Success Story of Donor Funding to 
Uganda Blood Transfusion Service, Vox Sanguinis 2010;99 (suppl 1):513  
Linden JV, Bianco C (Eds.) (2001). Blood Safety and Surveillance, Marcel Dekker, 0-8247-0263-
8, New York 
Los APM, Mutegombwa SM, Gabra GA, Smit Sibinga CTh. (2009) Liaison role of school 
teachers to support blood collection, donor motivation and retention at schools in Africa: 
Could the Uganda experience serve as an example for other African countries? Africa 
Sanguine 2009;12:5-10 
Los APM, Smit Sibinga CTh. (2001) Community involvement: The Development – the Past, 
the Present and the Future of Blood Donation as a Form of Community 
Involvement. In: Transfusion Medicine: Quo Vadis? What has been achieved, what 
is to be expected. Smit Sibinga CTh & Cash JD. (Eds.). pp21-29.  
Los APM, Smit Sibinga CTh. (2009) Social marketing tools to improve blood collection and donor 
retention, Vox Sanguinis 2009;96 (suppl. 1):124 (abstract P-147) 
Makhmudova MR, Smit Sibinga CTh. (2008) Creation of a National blood program in Uzbekistan, 
Vox Sanguinis, 2008;95 (Suppl 1):218 (P440) 
Martucci J. (2010). Negotiating exclusion: MSM, identity, and blood policy in the age of AIDS, Soc 
Stud Sci, Vol. 40, Issue 2 (April 2010), pp. 215-41 
McCullough J. (1998). Transfusion Medicine, McGraw-Hill, 0-07-045113-3, New York 
McFarland W et al. (1998). Risk factors for HIV seropositivity among first-time blood donors in 
Zimbabwe, Transfusion, Vol. 38, Issue 3 (March 1998), pp. 279-84 
Mintz PD. (1995). Quality assessment and improvement of transfusion practices, Hematol Oncol 
Clin North Am., Vol. 9, Issue 1 (February 1995), pp. 219-32 
www.intechopen.com
  
HIV and AIDS – Updates on Biology, Immunology, Epidemiology and Treatment Strategies 
 
616 
Noumsi GT, Schneider WH, Lachenal G, Smit Sibinga CTh. Use of blood donor screening data 
to access HIV dynamics in Cameroun,  Vox Sang 2008;95 (Suppl 1):261 (P559) 
Parry E.H.O. (Ed.). (1984) Principles of Medicine in Africa, 2d Edition, Oxford Medical 
Publications, 0192613375, Nairobi 
Perlin T. (2001). TKTK, In: Ethical issues in transfusion medicine, Macpherson CR, Domen 
RE, Perlin T, Editors, pp. TK-TK, AABB Press, 978-1563951381, Bethesda 
Roussel P et al. (2001). Methodologic contribution to blood transfusion materials surveillance, 
Transfus Clin Biol, Vol. 8, Issue 4 (August 2001), pp. 359-73 
Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW & Allain JP. (2001). 
Screening for viral markers in volunteer and replacement blood donors in West Africa, Vox 
Sanguinis, Vol. 80, pp. 142–7 
Smit Sibinga CT, Los APM, van der Tuuk Adriani WPA. Project management as a 
recommendable approach to improve donor management in restricted economy countries 
(preliminary results), Vox Sanguinis, 2006;91 (Suppl 3):191 (P-405) 
Smit Sibinga CT. Needs and essentials for Nationally supported structure and organisation of the 
blood supply: the Sanquin model, Transfusion 2006;46(Supplement):192A 
Smit Sibinga CTh, Kajja I. (2009). How to determine the needs for safe blood in Africa – 
expectations and realities. Programme and Abstracts book 5th International Congress 
AfSBT, Nairobi, KY 2009: F56 p.97 
Smit Sibinga CTh, van der Does JA, Los APM, Molijn HM, van der Tuuk Adriani WPA. 
(2009) Opzet en ontwikkeling van de bloedvoorziening in ontwikkelingslanden. Hoe doe je 
dat? Tijdschrift voor Bloedtransfusie 2009;2:87-92. 
Smit Sibinga CTh. (2000). Transfusion medicine in developing countries, Transfusion Medicine 
Reviews 2000;14:269-274. 
Smit Sibinga CTh. (2001) Risk management: an important tool for improving quality. Transfusion 
and Clinical Biology 2001;8:214-17. 
Smit Sibinga CTh. (2002). GCBS, ICBS and other initiatives; Will there be a ‘toto pro partum’? In: 
Transmissible Diseases and Blood Transfusion. Smit Sibinga CTh, Dodd RY (eds.). 
pp 195-202. Kluwer Academic Publishers ISBN 1-4020-0986-0. Dordrecht/ 
Boston/London  
Smit Sibinga CTh. (2006). Needs and essentials for Nationally supported structure and organisation 
of the blood supply: the Sanquin model, Transfusion, 2006;46(Supplement):192A 
Smit Sibinga, CTh. (2007). Detecting and Monitoring Reactions in the Developing World, In: 
Transfusion Reactions. Popovsky, MA, ed.  3rd edition AABB Press, Bethesda, MD, 
USA, 449-65 
Smit Sibinga CTh. (2008). The need for post-academic leadership development and  transfusion 
medicine related health sciences research. The Academic Institute for International 
Development of Transfusion Medicine. Transfusion Today 2008;77:9 
Smit Sibinga CTh. (2009). Is the need for safety of the blood supply in Africa different from other 
resource limited parts of the world? Programme and Abstracts book 5th International 
Congress AfSBT, Nairobi, KY June 2009: T29 p.72 
Smit Sibinga CTh. (2009a). Filling a gap in transfusion medicine education and research, 
Transfusion Medicine Reviews 2009;23;284-291 
Smit Sibinga CTh. (2009b). Pioneers and pathfinders – C.Th. Smit Sibinga: an autobiography, 
Transfusion Medicine Reviews 2009;23:160-165. 
www.intechopen.com
 Transmission of HIV Through Blood – How To Bridge the Knowledge Gap   
 
617 
South African National Blood Service [SANBS]. (2006) Donor Form, Accessed March 23, 
2011, Available from: http://www.sanbs.org.za/new_donors/Eng_SEQ.pdf 
Stutzer A & Goette L. (2010). Blood donor motivation: what is ethical? What works? ISBT Science 
Series, Vol. 5 (2010), pp. 244–248 
Thomas WI & Thomas DS (eds,). (1928). The child in America. Alfred Knopf, New York 
USA  
Titmuss R. (1971). The Gift Relationship: From Human Blood to Social Policy, New Press, 
1565844033, New York 
Umeora OU at al. (2005). Socio-cultural barriers to voluntary blood donation for obstetric use in a 
rural Nigerian village, African Journal of Reproductive Health, Vol. 9, Issue 3 
(December 2005), pp. 72-76 
United Nations. (1948) Universal Declaration of Human Rights. 22 March 2011 Avalailable 
from:  www.un.org/en/documents/udhr/index.shtml 
United Nations. (2000). Millennium Development Goals. 22 March 2011 Availble from:  
www.un.org/millenniumgoals/ 
United States Centers for Disease Control and Prevention [CDC]. (1982). Possible transfusion-
associated acquired immune deficiency syndrome (AIDS) – California, MMWR Morbidity 
and Mortality Weekly Report, Vol. 31, pp. 652-654 
United States Centers for Disease Control and Prevention [CDC]. (2008. Progress Towards 
Strengthening Blood Transfusion Srvices – 14 Countries, 2003-2007, MMWR Morbidity 
and Mortality Weekly Report, Vol. 57, pp. 1273-1277 
United States Food and Drug Administration [FDA]. (2010). CPG Sec. 230.150 Blood Donor 
Classification Statement, Paid or Volunteer Donor (05/07/2002 new), In: 
Compliance Policy Guides, Accessed March 27, 2011, Available from: 
http://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceMa
nual/ucm122798 
United States Food and Drug Administration [FDA]. (2010). Compliance Manual, Part I: 
Background, In: Inspection of Licensed and Unlicensed Blood Banks, Brokers, 




United States President's Emergency Plan for AIDS Relief. (2011) 2005-2010 PEPFAR Annual 
Reports, In: Annual Report to Congress on the President's Emergency Plan for 
AIDS Relief, Accessed March 23, 2011, Available from: 
http://www.pepfar.gov/press/c19573.htm 
van Hulst M, Sagoe KW, Vermande JE, van de Schaaf IP, van der Tuuk Adriani WP, Torpey 
K, Ansah J, Mingle JA, Smit Sibinga CT, Postma MJ. (2008). Cost-effectiveness of HIV 
screening of blood donations in Accra (Ghana), Value Health 2008;11:809-19. 
van Hulst M, Smit Sibinga CTh, Postma MJ. (2009). Health economics of blood transfusion safety 
– focus on sub-Saharan Africa, Biologicals 2009;doi:10.1016/j.biologicals.2009:1-6 
van Hulst R, Dhingra N, Smit Sibinga CT, Postma MJ. (2006). Cost-effectiveness of interventions 
ensuring blood transfusion safety in Africa, Transfusion 2006;46 (Supplement):169A 
Wehrli J.  (2011). The nuts and bolts of curriculum and assessment, Journal of Clinical Apheresis, 
Vol. 26, Issue 1 (ePub December 2010), pp. 29-46 
www.intechopen.com
  
HIV and AIDS – Updates on Biology, Immunology, Epidemiology and Treatment Strategies 
 
618 
World Bank in collaboration with U.S. CDC/CAR, USAID and WHO-EURO. (2008). Blood 
Services in Central Asian Health Systems: A clear and present danger of spreading 
HIV/AIDS and other infectious diseases. The International Bank for Reconstruction 
and Development/The World Bank, Washington DC, USA 
World Health Organization. (1978). WHA28.72 Utilization and supply of human blood and blood 
products. WHO 1978, Geneva CH 
World Health Organization. (1992a). Report of the GCBS informal consultation on ‘Assessment of 
Training Needs in Transfusion Medicine’. WHO_LBS_92.6, 1992, Geneva, CH 
World Health Organization. (1992b). Report of the GCBS informal consultation on ‘Collaboration 
in Training in Transfusion Medicine’. WHO_LBS_92.71, 1992, Geneva, CH 
World Health Organization (2001)  The Clinical Use of Blood. Handbook. WHO/BTS/99.3, 
2001, Geneva, CH 
World Health Organization. (2008b). Global Database on Blood Safety. Report 2004-2005, WHO 
2008 Geneva, CH 
World Health Organization. (2008c). Aide Mémoire for National Policy Makers. Good Policy 
Process for Blood Safety and Availability. WHO/EHT/08.02. January 2008, Geneva, 
CH 
World Health Organization. (2010a). Global Blood Safety and Availability. Facts and figures from 
the 2007 survey. WHO 2010, Geneva, CH 
World Health Organization. (2010b). Screening donated blood for transfusion-transmissible 
infections: recommendations. World Health Organization. ISBN 978-92-4-154788-8 
World Health Organization. (2008a). Universal access to safe Blood Transfusion 
WHO/EHT/08.03, Geneva, CH 
World Health Organization. (2009). Screening donated blood for transfusion-transmissible 
infections: recommendations, In: Research Policy, Accessed March 26, 2011, Available 
from: http://www.who.int/rpc/guidelines/9789241547888/en/index.html 
World Health Organization. (2011a). Blood Transfusion Safety, In: National Blood Policies, 
Accessed March 23, 2011, Available from: 
http://www.who.int/bloodsafety/transfusion_services/nat_blood_pol/en/ 
World Health Organization. (2011b). World Health Assembly/Executive Board Resolutions 
on Blood Safety, In: Blood transfusion safety documentation centre, Accessed 
March 23, 2011, Available from: 
http://www.who.int/bloodsafety/publications/en/index.html 
World Health Organization. (2011c). Aide-Memoire on Blood Safety for National Blood 
Programmes, In: Documentation, Accessed March 23, 2011, Available from: 
http://www.who.int/bloodsafety/publications/en/index.html 
World Health Organization. (2011d). Global Database on Blood Safety, In: Blood transfusion 
safety, Accessed March 25, 2011, Available from: 
http://www.who.int/bloodsafety/global_database/en/ 
www.intechopen.com
HIV and AIDS - Updates on Biology, Immunology, Epidemiology
and Treatment Strategies
Edited by Dr. Nancy Dumais
ISBN 978-953-307-665-2
Hard cover, 694 pages
Publisher InTech
Published online 26, October, 2011
Published in print edition October, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The continuing AIDS pandemic reminds us that despite the unrelenting quest for knowledge since the early
1980s, we have much to learn about HIV and AIDS. This terrible syndrome represents one of the greatest
challenges for science and medicine. The purpose of this book is to aid clinicians, provide a source of
inspiration for researchers, and serve as a guide for graduate students in their continued search for a cure of
HIV. The first part of this book, â€œFrom the laboratory to the clinic,â€ ​ and the second part, â€œFrom the
clinic to the patients,â€ ​ represent the unique but intertwined mission of this work: to provide basic and clinical
knowledge on HIV/AIDS.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Smit Sibinga, Cees Th and John P. Pitman (2011). Transmission of HIV Through Blood – How To Bridge the
Knowledge Gap, HIV and AIDS - Updates on Biology, Immunology, Epidemiology and Treatment Strategies,
Dr. Nancy Dumais (Ed.), ISBN: 978-953-307-665-2, InTech, Available from:
http://www.intechopen.com/books/hiv-and-aids-updates-on-biology-immunology-epidemiology-and-treatment-
strategies/transmission-of-hiv-through-blood-how-to-bridge-the-knowledge-gap
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
